Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Jefferies Upgrades Antofagasta And Glencore

Wed, 25th Nov 2020 09:28

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

----------

FTSE 100

----------

JEFFERIES RAISES ANTOFAGASTA TO 'BUY' ('HOLD') - TARGET 1,400 (1,100) PENCE

----------

JEFFERIES RAISES GLENCORE TO 'BUY' ('HOLD') - TARGET 250 (175) PENCE

----------

DEUTSCHE BANK RAISES GLENCORE PRICE TARGET TO 250 (240) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES DIAGEO TO 'OUTPERFORM' (NEUTRAL) - PRICE TARGET 3,450 (2,750) PENCE

----------

BANK OF AMERICA RAISES DIAGEO PRICE TARGET TO 3,550 (3,300) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS IMPERIAL BRANDS PRICE TARGET TO 1,580 (1,590) PENCE - 'NEUTRAL'

----------

UBS CUTS COMPASS GROUP PRICE TARGET TO 1,400 (1,420) PENCE - 'NEUTRAL'

----------

UBS CUTS B&M TO 'NEUTRAL' ('BUY') - TARGET 505 (425) PENCE

----------

JPMORGAN RAISES MELROSE INDUSTRIES TARGET TO 185 (165) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES NATWEST PRICE TARGET TO 150 (130) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS RAISES STANDARD CHARTERED TARGET TO 410 (400) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES LLOYDS PRICE TARGET TO 45 (40) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES BARCLAYS PRICE TARGET TO 145 (130) PENCE - 'EQUAL-WEIGHT'

----------

CREDIT SUISSE RAISES CRH PRICE TARGET TO 43 (41) EUR - 'OUTPERFORM'

----------

JEFFERIES RAISES CRH PRICE TARGET TO 38.70 (38.20) EUR - 'BUY'

----------

JPMORGAN RAISES CRH PRICE TARGET TO 40 (37) EUR - 'OVERWEIGHT'

----------

DZ BANK RAISES FAIR VALUE FOR CRH TO 39.5 (38.5) EUR - 'BUY'

----------

GOLDMAN SACHS CUTS PENNON GROUP PRICE TARGET TO 1,082 (1,149) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS CUTS SAGE GROUP PRICE TARGET TO 550 (600) PENCE - 'SELL'

----------

JPMORGAN CUTS SAGE GROUP PRICE TARGET TO 560 (600) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES AUTO TRADER GROUP TARGET TO 420 (348) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES INFORMA PRICE TARGET TO 440 (389) PENCE - 'NEUTRAL'

----------

HSBC RAISES WHITBREAD PRICE TARGET TO 3,900 (3,095) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS INTERTEK PRICE TARGET TO 6,530 (6,630) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

HSBC CUTS GREENCORE TO 'HOLD' ('BUY') - TARGET 120.1 (209.9) PENCE

----------

PEEL HUNT RAISES GENUS PRICE TARGET TO 4,600 (3,470) PENCE - 'HOLD'

----------

LIBERUM RAISES GENUS PRICE TARGET TO 4,490 (4,320) PENCE - 'BUY'

----------

LIBERUM RAISES PETS AT HOME PRICE TARGET TO 420 (350) PENCE - 'HOLD'

----------

BERENBERG RAISES PETS AT HOME PRICE TARGET TO 480 (450) PENCE - 'BUY'

----------

JPMORGAN RAISES BABCOCK INTERNATIONAL TARGET TO 405 (308) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES ROTORK PRICE TARGET TO 310 (300) PENCE - 'OVERWEIGHT'

----------

RBC CUTS PETROFAC PRICE TARGET TO 255 (330) PENCE - 'SECTOR PERFORM'

----------

JEFFERIES RAISES KAZ MINERALS PRICE TARGET TO 670 (640) PENCE - 'HOLD'

----------

RBC RAISES BREWIN DOLPHIN HOLDINGS PRICE TARGET TO 360 (350) PENCE - 'OUTPERFORM'

----------

LIBERUM CUTS BREWIN DOLPHIN HOLDINGS PRICE TARGET TO 345 (350) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES ASHMORE GROUP TARGET TO 422 (417) PENCE - 'EQUAL-WEIGHT'

----------

BANK OF AMERICA RAISES INVESTEC PRICE TARGET TO 212 (180) PENCE - 'BUY'

----------

JEFFERIES CUTS BEAZLEY PRICE TARGET TO 430 (470) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

JPMORGAN INITIATES CLINIGEN WITH 'NEUTRAL' - TARGET 650 PENCE

----------

LIBERUM RAISES AB DYNAMICS PRICE TARGET TO 2,300 (2,100) PENCE - 'BUY'

----------

JEFFERIES RAISES FORTERRA PRICE TARGET TO 231 (200) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES FORTERRA PRICE TARGET TO 259 (234) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES BANK OF IRELAND TARGET TO 3 (2,20) EUR - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES ALLIED IRISH BANKS TARGET TO 1,45(1,30)EUR 'EQUAL-WEIGHT'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
10 Oct 2019 10:50

Clinigen Inks Partnership To Sell Tumor Treatment Azedra Outside US

Clinigen Inks Partnership To Sell Tumor Treatment Azedra Outside US

Read more
3 Oct 2019 09:34

BROKER RATINGS SUMMARY: Peel Hunt Raises Flutter Entertainment To Hold

BROKER RATINGS SUMMARY: Peel Hunt Raises Flutter Entertainment To Hold

Read more
30 Sep 2019 09:55

BROKER RATINGS SUMMARY: Barclays Cuts Whitbread And Raises SSE

BROKER RATINGS SUMMARY: Barclays Cuts Whitbread And Raises SSE

Read more
19 Sep 2019 13:29

Thursday broker round-up

(Sharecast News) - Ferguson: RBC Capital Markets downgrades to underperform with a target price of 5,100p.

Read more
19 Sep 2019 10:36

Clinigen Profit Drops On One-Off Costs, Despite Strong Revenue Growth

(Alliance News) - Clinigen Group PLC said Thursday annual profit dropped sharply on higher amortisation costs on acquired intangibles and acquisition expenses, despite strong revenue the financial

Read more
12 Sep 2019 16:21

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 13 September  JD WetherspoonFull Year ResultsSthreeQ3 Enterprise Investment

Read more
16 Jul 2019 10:04

Clinigen Expects Increased Annual Profit On Strong Acquisitions

(Alliance News) - Clinigen Group PLC said Thursday it expects to see a double-digit rise in profit and revenue for its recently ended financial year, driven by contributions from the year to the a

Read more
16 May 2019 06:45

CORRECT: Clinigen Retakes Ethyol And Totect US Commercial Rights

(Correcting the headline to clarify that Clinigen already had the products in its portfolio).LONDON (Alliance News) - Clinigen Group PLC on Wednesday said it has agreed to retake the US to

Read more
15 May 2019 12:43

Clinigen to take back US rights to cancer drugs

(Sharecast News) - Aim's Clinigen Group is taking back control of two oncology drugs from US partner Cumberland Pharmaceuticals.

Read more
2 Apr 2019 10:57

Clinigen monopolises global rights for skin cancer treatment

(Sharecast News) - Clinigen now owns the global rights to Proleukin after having acquired the US rights to the treatment on Tuesday following US anti-trust clearance.

Read more
27 Feb 2019 10:23

Clinigen earnings grow following CSM and iQone acquisitions

(Sharecast News) - Specialty pharmaceuticals group Clinigen saw strong earnings and cash flow growth in the first half of its trading year following a period of transformative acquisitions.

Read more
27 Feb 2019 08:55

Clinigen Group Reports "Good" Interim Performance As Revenue Rises

LONDON (Alliance News) - Clinigen Group PLC on Wednesday described its interim performance as "good", with revenue rising 24%, but profit did fall on the prior year.For the six to

Read more
20 Feb 2019 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 21 February BAE SystemsFull Year ResultsRELXFull Year Year AmericanFull

Read more
20 Feb 2019 13:19

Wednesday broker round-up

(Sharecast News) - Ocado: Peel Hunt downgrades to hold with a target price of 110p.

Read more
13 Feb 2019 12:50

Wednesday broker round-up

(Sharecast News) - Workspace Group: Berenberg downgrades to hold with a target price of 900p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.